CGTX Cognition Therapeutics
- 0.514
- -0.051-9.08%
Cognition Therapeutics News
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 10-Q: Q2 2024 Earnings Report
Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kreis Leslie W.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fletcher Aaron G.L.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wallace Peggy
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHSTONE ELLEN B
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Monia Brett P
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 10-Q: Q1 2024 Earnings Report
Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle John Brendan
Cognition Therapeutics | ARS: Annual Report to Security Holders
Cognition Therapeutics | DEFA14A: Others
Cognition Therapeutics | DEF 14A: Definitive information statements
Cognition Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
No Data